Tolperisone: Clinical Trials

7 trials of Tolperisone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 unknown. 3 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Completed 1
Phase 12Completed 2
Phase 32Completed 1, Unknown 1

Follow Tolperisone: new trials by email Literature Review of Tolperisone trials Research Report on Tolperisone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm
Tolperisone Hydrochloride, Placebo - Back Muscle Spasm, Back Pain
Phase 3CompletedNeurana Pharmaceuticals, Inc.10042020-12-152022-03-22
A Phase 1 PK Study of Tolperisone in Healthy Subjects
Tolperisone - Healthy
Phase 1CompletedNeurana Pharmaceuticals, Inc.272020-07-282022-02-01
Effects of Tolperisone on Measures of Drowsiness and Cognitive Function
Tolperisone Hydrochloride, Cyclobenzaprine Hydrochloride 10 MG, Placebo - Healthy
Phase 1CompletedNeurana Pharmaceuticals, Inc.392020-06-202022-02-01
The Prognostic Value of Biomarkers and the Effect of Tolperisone in Acute Low Back Pain and Sciatic Pain "BETA"
Tolperisone Hydrochloride, Placebo - Low Back Pain
Phase 3UnknownSemmelweis University1502019-12-132024-04-17
Tolperisone in Acute Muscle Spasm of the Back
Tolperisone, Placebo - Back Pain, Acute Pain
Phase 2CompletedNeurana Pharmaceuticals, Inc.4152019-02-012022-02-01
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
tolperisone HCl (AV650), Placebo - Muscle Spasticity
Phase 2TerminatedAvigen1202007-09-012008-11-04
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
tolperisone HCl - Muscle Spasticity
Phase 2TerminatedAvigen1502007-09-012008-11-04

Conditions studied

Back Pain (3)  ·  Acute Pain (2)  ·  Low Back Pain (2)  ·  Muscle Spasticity (2)  ·  Spasm (2)  ·  Multiple Sclerosis (1)  ·  Muscle Cramp (1)  ·  Spinal Cord Injuries (1)

Sponsors

Neurana Pharmaceuticals, Inc. (4)  ·  Avigen (2)  ·  Semmelweis University (1)

Countries

United States (5)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Russia (1)  ·  Serbia (1)  ·  Ukraine (1)

Top investigators

Daniel Bereczki, MD, POhD,DSc (1)  ·  Glenn Morrison, MSc, PhD (1)  ·  Ralph J Marino, MD (1)

Results publications

PMID 34192885